Dali Pharmaceuticalco.,Ltd

SHSE:603963 Stock Report

Market Cap: CN¥681.1m

Dali Pharmaceuticalco.Ltd Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 603963?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,937,3772.25%
VC/PE Firms29,659,50013.5%
Private Companies41,073,75018.7%
General Public58,624,32326.7%
Individual Insiders85,405,05038.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 13 shareholders own 73.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.3%
Jun Xiang Yang
51,204,200CN¥158.7m0%no data
18.7%
Lixing Industrial Co., Ltd.
41,073,750CN¥127.3m0%no data
13.5%
Xinjiang Lixing Equity Investment Management Co., Ltd.
29,659,500CN¥91.9m0%no data
11.9%
Qing Yang
26,232,180CN¥81.3m0%no data
3.06%
Cui Xian Yin
6,722,820CN¥20.8m0%no data
0.63%
Goldman Sachs Group, Investment Banking and Securities Investments
1,382,500CN¥4.3m0%no data
0.56%
Jun Wei Yang
1,235,850CN¥3.8m0%no data
0.41%
CITIC Securities Company Limited, Asset Management Arm
906,741CN¥2.8m0%no data
0.36%
Huatai Securities (Shanghai) Asset Management Co., Ltd.
782,009CN¥2.4m0%0.02%
0.3%
China International Capital Corporation Hong Kong Asset Management Limited
650,334CN¥2.0m0%0.01%
0.29%
Barclays PLC Private Banking & Investment Banking Investment
635,946CN¥2.0m0%no data
0.26%
JPMorgan Chase & Co, Brokerage and Securities Investments
579,847CN¥1.8m0%no data
0.0046%
Peirong Wu
10,000CN¥31.0k0%no data